Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Dana W.Y. Tsui"'
Autor:
Carlos A. Ruiz-Perez, Prachi Nakashe, Maggie A. Marshall, Francesco Marass, Tuong Tang, Lisa M. McLennan, Marissa Kroll, Brian K. Flesner, Suzanne Gray, Jill M. Rafalko, Daniel S. Grosu, Susan C. Hicks, John A. Tynan, Dana W.Y. Tsui, Andi Flory, Kristina M. Kruglyak
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
This proof-of-concept evaluation demonstrates that next-generation sequencing-based liquid biopsy can detect genomic alterations in the blood of cats with cancer and the absence of such alterations in the blood of presumably cancer-free cats. Two cat
Externí odkaz:
https://doaj.org/article/574a27c2e3a84f46ba3a5b5f33382d63
Autor:
Prachi Kothari, Francesco Marass, Julie L. Yang, Caitlin M. Stewart, Dennis Stephens, Juber Patel, Maysun Hasan, Xiaohong Jing, Fanli Meng, Jeanette Enriquez, Kety Huberman, Agnes Viale, Jasmine H. Francis, Michael F. Berger, Neerav Shukla, David H. Abramson, Ira J. Dunkel, Dana W.Y. Tsui
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6093-6101 (2020)
Abstract Purpose The enucleation rate for retinoblastoma has dropped from over 95% to under 10% in the past 10 years as a result of improvements in therapy. This reduces access to tumor tissue for molecular profiling, especially in unilateral retinob
Externí odkaz:
https://doaj.org/article/0a8e616f72034103b531f13b624076ea
Autor:
Kristina M. Kruglyak, Jason Chibuk, Lisa McLennan, Prachi Nakashe, Gilberto E. Hernandez, Rita Motalli-Pepio, Donna M. Fath, John A. Tynan, Lauren E. Holtvoigt, Ilya Chorny, Daniel S. Grosu, Dana W.Y. Tsui, Andi Flory
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
This proof-of-concept study demonstrates that blood-based liquid biopsy using next generation sequencing of cell-free DNA can non-invasively detect multiple classes of genomic alterations in dogs with cancer, including alterations that originate from
Externí odkaz:
https://doaj.org/article/bccc16909c96432baa284a9e10aaeb7b
Autor:
David H. Abramson, MD, Diana Mandelker, MD, PhD, Jasmine H. Francis, MD, Ira J. Dunkel, MD, A. Rose Brannon, PhD, Ryma Benayed, PhD, Michael F. Berger, PhD, Maria E. Arcila, MD, Marc Ladanyi, MD, Danielle Novetsky Friedman, MD, Gowtham Jayakumaran, MS, Monica S. Diosdado, MA, Melissa A. Robbins, MPH, Dianna Haggag-Lindgren, BS, Neerav Shukla, MD, Michael Walsh, MD, Prachi Kothari, DO, Dana W.Y. Tsui, PhD
Publikováno v:
Ophthalmology Science, Vol 1, Iss 1, Pp 100015- (2021)
Purpose: Analysis of circulating tumor DNA (ctDNA) in the plasma of patients with retinoblastoma and simulating lesions. Design: Retrospective cross-sectional study of the association of plasma ctDNA from retinoblastoma and simulating lesions with di
Externí odkaz:
https://doaj.org/article/9c664857dfd245da8feebe8a194e22df
Autor:
Kevin M. Brindle, Nitzan Rosenfeld, Colin Watts, Alan J. Wright, Charles E. Massie, Dana W.Y. Tsui, Francesco Marass, Davina Gale, Dineika Chandrananda, Christopher G. Smith, Florent Mouliere, Richard Mair
This file presents the raw data for the cell free DNA experiments.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588d1fee8a87f8f0595349b1ab99dcd6
https://doi.org/10.1158/0008-5472.22421003
https://doi.org/10.1158/0008-5472.22421003
Autor:
Connie Lee Batlevi, Dana W.Y. Tsui, Anas Younes, Heiko Schöder, Venkatraman Seshan, Gilles Salles, Jurgen Rademaker, Andrew D. Zelenetz, Alison Moskowitz, Craig H. Moskowitz, Anita Kumar, Steven M. Horwitz, David Straus, Audrey Hamilton, Pamela Drullinsky, John F. Gerecitano, Matthew J. Matasar, Paul A. Hamlin, Stephanie De Frank, Chelsea Nichols, Reiko Nakajima, Karissa Whiting, Laure Michaud, Caitlin M. Stewart
Supplemental Figure S4. Progression-free survival Kaplan-Meier curves based on PET and ctDNA parameters. A. PFS based on baseline SUV categorized into lower and higher than median. B. PFS based on baseline tumor glycolysis level lower or higher than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ce9f1cf6501ca24e42ec44622659cac
https://doi.org/10.1158/1078-0432.22482297
https://doi.org/10.1158/1078-0432.22482297
Autor:
Kevin M. Brindle, Nitzan Rosenfeld, Colin Watts, Alan J. Wright, Charles E. Massie, Dana W.Y. Tsui, Francesco Marass, Davina Gale, Dineika Chandrananda, Christopher G. Smith, Florent Mouliere, Richard Mair
This file presents demographic information across the different PDOX populations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c0177ce9fefb176aff160f05ef5cfa
https://doi.org/10.1158/0008-5472.22421006
https://doi.org/10.1158/0008-5472.22421006
Autor:
Connie Lee Batlevi, Dana W.Y. Tsui, Anas Younes, Heiko Schöder, Venkatraman Seshan, Gilles Salles, Jurgen Rademaker, Andrew D. Zelenetz, Alison Moskowitz, Craig H. Moskowitz, Anita Kumar, Steven M. Horwitz, David Straus, Audrey Hamilton, Pamela Drullinsky, John F. Gerecitano, Matthew J. Matasar, Paul A. Hamlin, Stephanie De Frank, Chelsea Nichols, Reiko Nakajima, Karissa Whiting, Laure Michaud, Caitlin M. Stewart
Supplemental Figure S3. A. Waterfall plot based on RECIL criteria. RECIL introduces the minimal response category which is a 10-30% reduction in the sum of longest diameters of target lesions. B. Event-free survival Kaplan-Meier curve.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d8ebb51c332dea0175df8bd9d9e7b1
https://doi.org/10.1158/1078-0432.22482300.v1
https://doi.org/10.1158/1078-0432.22482300.v1
Autor:
Kevin M. Brindle, Nitzan Rosenfeld, Colin Watts, Alan J. Wright, Charles E. Massie, Dana W.Y. Tsui, Francesco Marass, Davina Gale, Dineika Chandrananda, Christopher G. Smith, Florent Mouliere, Richard Mair
The factors responsible for the low detection rate of cell-free tumor DNA (ctDNA) in the plasma of patients with glioblastoma (GBM) are currently unknown. In this study, we measured circulating nucleic acids in patient-derived orthotopically implante
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f499e61cdf1602533916ab7eca0dc1e
https://doi.org/10.1158/0008-5472.c.6510809.v1
https://doi.org/10.1158/0008-5472.c.6510809.v1
Autor:
Connie Lee Batlevi, Dana W.Y. Tsui, Anas Younes, Heiko Schöder, Venkatraman Seshan, Gilles Salles, Jurgen Rademaker, Andrew D. Zelenetz, Alison Moskowitz, Craig H. Moskowitz, Anita Kumar, Steven M. Horwitz, David Straus, Audrey Hamilton, Pamela Drullinsky, John F. Gerecitano, Matthew J. Matasar, Paul A. Hamlin, Stephanie De Frank, Chelsea Nichols, Reiko Nakajima, Karissa Whiting, Laure Michaud, Caitlin M. Stewart
Supplemental Figure S2. A. Comparison of treatment-related and -unrelated adverse events occurring in >10% of evaluable patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6437507a47cb49cda51572fca203b53c
https://doi.org/10.1158/1078-0432.22482303
https://doi.org/10.1158/1078-0432.22482303